ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
174 hedge funds and large institutions have $291M invested in Antares Pharma, Inc. in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 50 increasing their positions, 53 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
6% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 53
59% less call options, than puts
Call options by funds: $595K | Put options by funds: $1.45M
Holders
174
Holding in Top 10
4
Calls
$595K
Puts
$1.45M
Top Buyers
| 1 | +$14.2M | |
| 2 | +$13.9M | |
| 3 | +$2.39M | |
| 4 |
Morgan Stanley
New York
|
+$1.56M |
| 5 |
BlackRock
New York
|
+$1.34M |
Top Sellers
| 1 | -$3.25M | |
| 2 | -$3.23M | |
| 3 | -$2.6M | |
| 4 |
MFAM
Motley Fool Asset Management
Alexandria,
Virginia
|
-$2.49M |
| 5 |
SAM
Silvercrest Asset Management
New York
|
-$1.41M |